Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Details

Autor(en) / Beteiligte
Titel
QOL and Survival Survey of Cancer Cachexia in Advanced NSCLC Patients - JNUQ-LC Study, TORG0912
Ist Teil von
  • Annals of oncology, 2012-09, Vol.23, p.ix511
Ort / Verlag
Elsevier BV
Erscheinungsjahr
2012
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • ABSTRACT Background Cancer cachexia, mainly characterized by muscle atrophy and subsequent cancer induced weight loss (CIWL), is attributed to about a third of cancer deaths. Despite worsening prognoses with the symptoms, clinical factors involved and the effect of CIWL to the overall status remain unexplained. We planned a prospective cohort study, Japan Nutrition and QOL survey in patients with advanced NSCLC study to investigate changes in CIWL in relation to grip, QOL, and clinical parameters to understand their effects on prognosis. Method Untreated stage IV NSCLC patients with ECOG PS of 0-2 were registered. Their body weight (BW), grip, QOL, Karnofsky Performance Scale, biochemical assay, and survival were recorded every four weeks for one year from the start of cancer treatments. Patients were classified by BW loss ≥ 5% and cachexia diagnosis by BW loss, fatigue, anorexia, and abnormal assay results. Estimated survival curves were drawn by Kaplan-Meier method, and Log-rank test was applied. To evaluate the effect of cancer cachexia attribution to QOL, we performed principal component analysis, factor analysis, and analysis on time course data using generalized estimating equation (GEE). Results Out of 466 patients registered, 406 were evaluable and analyzed. Patient characteristics were: median age: 67 (33-87) years, male/female ratio: 280/126, median BW: 56.5kg, PS 0: 39.2%, and PS 1: 51.5%. The patients with BW loss of ≥ 5% (n = 219) reported more early deaths than those without (n = 166, p  Conclusion Cancer cachexia decreased QOL and possibly affected prognoses. Cachexia preventions and treatments based on the further elucidation of its pathology are needed. Disclosure All authors have declared no conflicts of interest.
Sprache
Englisch
Identifikatoren
ISSN: 0923-7534
eISSN: 1569-8041
DOI: 10.1016/S0923-7534(20)34133-8
Titel-ID: cdi_crossref_primary_10_1016_S0923_7534_20_34133_8

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX